Navigation Links
Implant Shows Promise for Hard-to-Treat Epilepsy
Date:3/18/2010

Pacemaker-like device cut frequency of seizures in study participants,,

THURSDAY, March 18 (HealthDay News) -- Deep-brain electrical stimulation reduced the frequency of epileptic seizures in people who had not responded to other treatments, a new study has found.

The electrical stimulation came from a pacemaker-like device that was implanted under the skin of the participants' chest wall. Electrical leads from the device ran under the skin to the neck, behind the ear and through the skull to the thalamus, a "relay station" deep within the brain. The device delivers measured and timed electrical impulses to the brain.

Led by Stanford University researchers, the study included 110 adults with partial-onset epilepsy. At the start of the study, they typically had 20 seizures a month.

With the deep-brain stimulation, seizure frequency decreased by 40 percent in the first three months after the device was implanted, the study found. After about two years, seizures had decreased 56 percent, on average.

Adverse effects reported by the participants included infection at the site of implantation, misplaced electrical leads that had to be repositioned and tingling sensations.

The findings were published online March 18 in Epilepsia.

The study was sponsored by Medtronic, which makes the device, and study co-author Dr. Jaimie Henderson, an associate professor of neurosurgery at Stanford, reported receiving consulting fees from the company.

The U.S. Food and Drug Administration is considering whether to approve the device for treatment of epilepsy in people who don't respond to other therapies.

More information

The American Academy of Family Physicians has more about epilepsy.



-- Robert Preidt



SOURCE: Stanford University, news release, March 18, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Nanowire coating for bone implants, stents
2. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up
3. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
4. Implantable device designed to detect, stop seizures under study at MCG
5. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
6. Bone-growing nanomaterial could improve orthopaedic implants
7. RFID Implant Cancer Questions Concern Patients
8. GrantAdler Shipping Novel Implantable Vascular Access Port
9. SBi Launches rHead(TM) Lateral Radial Head Implant and rHead(TM) Plating Systems to Expand its Elbow Management System
10. Facet Solutions AFRS(TM) Implant Demonstrates Positive Clinical Results After One Year Follow Up
11. TyRx Pharma, Inc. Announces Presentation of Results to Benefit Women with Breast Implants (In-Vivo Efficacy Study Regarding AIGISRx DEB) at the Plastic Surgery 2007 Meeting on October, 28 2007 in Baltimore, MD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... ... March 30, 2017 , ... AudioEducator, ... conference “ Preventing Hospital Readmissions Through Discharge Planning ” with noted expert Sue ... ET. This conference discusses strategies to prevent readmissions in light of the most ...
(Date:3/29/2017)... ... 29, 2017 , ... During the last week of March, Chad Kawa, MD ... individuals in the local community. , Colon cancer is the second leading cause ... cancer while it is small, confined and easier to treat. If you are 50 ...
(Date:3/29/2017)... San Diego, CA (PRWEB) , ... March 29, 2017 , ... ... meningiomas(1,2), and up to 300,000 people each year develop other types of metastatic brain ... spread quickly throughout the brain(3). As efforts focus on finding more effective treatment options, ...
(Date:3/29/2017)... ... March 29, 2017 , ... Full Contact K9, an Atlanta-based ... Pet Protect Law that assists dog owners in creating legally-enforceable pet trusts for ... taking the natural next step to protect their new companion. Says Evan Dunbar, CEO ...
(Date:3/29/2017)... ... March 30, 2017 , ... CHARM CITY RUN WELCOMES MERCY MEDICAL ... that Mercy Medical Center will serve as the official title sponsor of the Baltimore ... June 25, 2017, thousands of women will walk or run the course around the ...
Breaking Medicine News(10 mins):
(Date:3/30/2017)... March 30, 2017  Lannett Company, Inc. (NYSE: ... made a $25 million payment against its existing revolving ... combined with the $75 million payment we made earlier ... million in annualized cash interest expense, at current rates" ... Lannett.  "Our business is solid and we continue to ...
(Date:3/30/2017)... Revenue Prospects by Product Type (Metered Dose ... Geography Respiratory Inhalers - our new study reveals trends, ... market heading? If you are involved in this sector you must ... the potential revenues streams to 2027, assessing data, trends, opportunities and ... ...
(Date:3/30/2017)... 30, 2017  Purcell Julie & Lefkowitz LLP, a class ... a potential breach of fiduciary duty claim involving the board ... ). If you are a shareholder of ... this investigation, free of charge, please visit us at: ... http://pjlfirm.com/synergy-pharmaceuticals-inc/ ...
Breaking Medicine Technology: